Shareholder Investigation of Syneos Health
Syneos Health, Inc. (SYNH) Accused of Improper Accounting Practices
According to the complaint against the company’s officers and directors for alleged violations of the Securities Exchange Act of 1934 between May 10, 2017 and February 27, 2019, on various quarterly and annual reports since 2017, Syneos Health, Inc. (SYNH) stated that its internal control over financial reporting was effective. However, on February 27, 2019, after market hours, Syneos announced it was delaying the release of its Form 10-K after the U.S. Securities and Exchange Commission started an investigation into Syenos’ revenue accounting policies and internal controls. On this news, shares of Syneos fell $10.24 per share or almost 20% to close at $41.77 per share on February 28, 2019.
Syneos Health, Inc. (SYNH) Shareholders Have Legal Options
Concerned shareholders who would like more information about their rights and potential remedies can please send us a message via the Shareholder Information form below.